Merlin Biomed Investor

As of December 2007, Merlin BioMed Group (MBG) has gone out of business. It was an employee owned investment manager. The firm primarily provides its services to pooled investment vehicles, institutions, pension funds, endowments, family offices, and high net worth individuals. It manages funds of hedge funds for its clients. The firm invests in the public equity and hedging markets across the globe. It primarily invests in small-cap, mid-cap, and large-cap companies to create its portfolios. The firm employs a fundamental analysis with a bottom-up stock picking approach to make its investments. It typically invests in companies operating in the biotechnology, pharmaceuticals, medical devices, and healthcare services industries. Merlin BioMed Group was founded in January 1998 and is based in New York, New York.
Technology: N/A
Industry: Regenerative Medicine
Headquarters: New York, New York, United States
Founded Date: 1988
Employees Number: undisclosed
Funding Status: undisclosed
Investor Type: Hedge Fund
Investment Stage: Late Stage Venture, Private Equity
Number Of Exits: 11

Visit Website
Register and Claim Ownership